Navigation Links
Mayo Clinic Study Finds Further Association Between Diabetes and Pancreatic Cancer
Date:1/23/2008

Study's authors recruit patients for a clinical trial, another step in this ongoing research

ROCHESTER, Minn., Jan. 23 /PRNewswire-USNewswire/ -- A new Mayo Clinic study found that 40 percent of pancreatic cancer patients are diagnosed with diabetes prior to their pancreatic cancer diagnosis. The onset of diabetes appears to be many months (in some cases up to two years) prior to cancer diagnosis. This information provides researchers an important clue for earlier detection of pancreatic cancer. The study was published in this month's issue of Gastroenterology.

"Our previous studies have shown an association between recent diagnoses of diabetes and pancreatic cancer," says Suresh Chari, M.D., a Mayo Clinic gastroenterologist and the study's lead author. "We are now quite convinced that in most patients with pancreatic cancer the diabetes is caused by the cancer and not the other way around. Our next step is to identify a biomarker for pancreatic cancer-induced diabetes in order to screen patients with new-onset diabetes for early pancreatic cancer and provide surgical treatment as quickly as possible."

More than 33,000 people die each year from pancreatic cancer, the fourth-leading cause of cancer death in the United States. Patients with this cancer seldom exhibit disease-specific symptoms until the cancer is at an advanced stage and surgery is no longer an option. Therefore, fewer than 5 percent of pancreatic cancer patients survive five years after diagnosis.

This study reviewed the medical records of 736 patients with pancreatic cancer and 1,875 healthy individuals with fasting blood glucose data in their medical record. Dr. Chari's team found that 40 percent of pancreatic cancer patients were diagnosed with diabetes, while only 20 percent of the healthy individuals had fasting blood glucose levels in the diabetic range.

Type 2 diabetes is far more common than pancreatic cancer-induced diabetes. According to a
'/>"/>

SOURCE Mayo Clinic
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., NEW YORK, Dec. 2 Reportlinker.co...vailable in its catalogue: ,, Hemoglobin A1c M...w.reportlinker.com/p0164230/Hemoglobin-A1c-Monitor...ness of affliction and the need for effective ther... a significant market for monitoring the treatment...
(Date:12/2/2009)..., NEW YORK, Dec. 2 Reportlinker.co...vailable in its catalogue: ,, Global Markets ...rtlinker.com/p0166826/Global-Markets-for-Asthma-an...ysis of the global market for medications that tre...e ,, Contains global market forecasts through 2...
(Date:12/2/2009)...ITTLE FALLS, N.J., Dec. 2 /PRNewswire-FirstCall/ -... the results for its first quarter ended October 3... hold a conference call to discuss the results at ...arles M. Diker, Chairman; Andrew A. Krakauer, Pres...dent; Craig A. Sheldon, Senior Vice President, CFO...
Breaking Medicine Technology:Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 2Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 3Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 4Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 5Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 6Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 7Reportlinker Adds Global Markets for Asthma and COPD Drugs 2Reportlinker Adds Global Markets for Asthma and COPD Drugs 3Reportlinker Adds Global Markets for Asthma and COPD Drugs 4Reportlinker Adds Global Markets for Asthma and COPD Drugs 5Reportlinker Adds Global Markets for Asthma and COPD Drugs 6Reportlinker Adds Global Markets for Asthma and COPD Drugs 7Reportlinker Adds Global Markets for Asthma and COPD Drugs 8Reportlinker Adds Global Markets for Asthma and COPD Drugs 9Reportlinker Adds Global Markets for Asthma and COPD Drugs 10Reportlinker Adds Global Markets for Asthma and COPD Drugs 11Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2009 2New York Personal Injury Attorney Defends Medical Malpractice 55474 1New York Personal Injury Attorney Defends Medical Malpractice 55474 2New York Personal Injury Attorney Defends Medical Malpractice 55474 3Studies show dramatic decline in rheumatoid vasculitis in US veterans 55469 1Studies show dramatic decline in rheumatoid vasculitis in US veterans 55469 2Breakthrough Technology Harnesses Microorganism for Use as Green Bio Pesticide 55467 1Breakthrough Technology Harnesses Microorganism for Use as Green Bio Pesticide 55467 2Breakthrough Technology Harnesses Microorganism for Use as Green Bio Pesticide 55467 3Breakthrough Technology Harnesses Microorganism for Use as Green Bio Pesticide 55467 4Breakthrough Technology Harnesses Microorganism for Use as Green Bio Pesticide 55467 5
...Austria, June 11 /PRNewswire-FirstCall/,-- Iomai C...blication of data,from the company,s positive Phas...e in The Lancet. The study, which analyzed data fr... Iomai patch-based vaccine were,statistically sign...gnificant diarrhea than their counterparts who rec...
...U today,announced that its WaveReady 3000 series h... Inc. as compatible with Brocade-based Storage Are...esting requirements of the,Brocade Data Center Rea...to,foster interoperability in multi-vendor Brocade... that JDSU has successfully completed the Data Cen...
Other Medicine Technology:Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 2Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 3Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 4Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 5Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 6Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 7JDSU WaveReady Receives Brocade Data Center Ready Status for Brocade-Based Storage Area Network (SAN) Infrastructures 2JDSU WaveReady Receives Brocade Data Center Ready Status for Brocade-Based Storage Area Network (SAN) Infrastructures 3
(Date:12/2/2009)...swire-USNewswire/ -- The American Association of P...pin Regional Poison Center in Minneapolis, Minneso...r milestone for the center. The designation by th... among 58 accredited poison centers in the United ...complishment. It means we have met the national st...
(Date:12/2/2009)...swire-USNewswire/ -- In response to a press confe... ," an initiative from the U.S. Anti-Doping Agen...r Responsible Nutrition (CRN), the leading trade a...ustry, issued the following statement: ,, Sta..., "We share the concerns of Travis Tygart (USAD...
(Date:12/2/2009)...ses, study finds , , WEDNESDAY, Dec. 2 (...al rates for advanced lung cancer patients in the ...has found. , Researchers analyzed data on more ...mall cell lung cancer (NSCLC) between 1990 and 200...l Cancer Institute,s Surveillance, Epidemiology an...
(Date:12/2/2009)... unclear, researchers say , , WEDNESDAY,...that enzyme replacement therapy can make a major d...e, a rare illness that affects the kidneys, heart ...o the lack of an enzyme that helps metabolic pathw...boosts the risk for a stroke, heart attack and kid...
(Date:12/2/2009)... Researchers from aroun...ancer research at the annual American Society of H... 4-8, 2009. ,, Throughout the ASH conference, ... including Chief Medical Officer Barton Kamen, M.D...s Hildy Dillon, and Vice President, Research Commu...
Breaking Medicine News(10 mins):Health News:Hennepin Regional Poison Center Designated as an Accredited Poison Control Center 2Health News:CRN Responds to 'Supplement Safety Now' Initiative 2Health News:CRN Responds to 'Supplement Safety Now' Initiative 3Health News:Gains Made in Lung Cancer Survival 2
...Byrd Alzheimer,s Institute Shows Cognitive Activit...Against Memory Loss, TAMPA, Fla., Sept. 12 New r...lifelong activities, only a high level of,mental o...Byrd Institute researchers raised Alzheimer,s mice...
...ad to new drug to treat manic phase of the illness...thDay News) -- The breast cancer drug tamoxifen he...nd works faster than many standard medications use...e this long period before they start to work," exp...
.... 12, 2007 Rice University chemists have discover...ancer drug paclitaxel onto tiny gold spheres. The ...iving cell that literally bristles with the drug. ...e most effective anti-cancer drugs, and many resea...
... Sept. 12 A new, free white paper,details how OSF... has,substantially reduced lift injuries while boo...w lift team department that provides patient trans... Portal, (http://www.safeliftingportal.com ), a pr...
...developed psoriasis at the age of 5; as a teenager...red 70 percent of her body.,Today, her curse is he...l,Psoriasis Foundation, PORTLAND, Ore., Sept. 12 ...y, Sept.,29, at Mission Bay Park. The event featur...
...pt. 12 Psychemedics,Corporation (Amex: PMD ) was...alent Officer, an innovative new book sponsored by...t issues and the growing imperative for,HR leaders...ive approaches to leading,and managing human capit...
Other Medicine News:Health News:Cognitive Activities Protect Against Alzheimer's -- Social and Physical Activities Not Enough 2Health News:Tamoxifen Helps Treat Bipolar Disorder 2Health News:Tamoxifen Helps Treat Bipolar Disorder 3Health News:Taxol bristle ball: a wrench in the works for cancer 2Health News:New Case Study Details How an Illinois Hospital Created a Safe Lifting Team that Dramatically Reduced Injuries, Increased Staff Satisfaction 2Health News:America's Next Top Model Steps up for Psoriasis Awareness 2Health News:Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book 2Health News:Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book 3
Lawson Lite
High Lite Sport
KX-21N™ Automated Hematology Analyzer
...designed,for the rapid, qualitative detection of...nt throat specimens. The kit is,self-contained a... perform 25 or 50 tests including the throat swabs...,for the rapid, qualitative detection of Group A...
Medicine Products: